期刊文献+

抗菌肽对种植体周围炎主要致病菌生长抑制作用的研究 被引量:6

Inhibitory effect of antimicrobial peptides on peri-implantitis pathogens in vitro
原文传递
导出
摘要 目的研究抗菌肽KSL及其衍生物KSL-W对种植体周围炎主要致病菌的体外抑菌效果。方法应用二倍稀释法检测KSL和KSL-W对血链球菌、具梭核杆菌和牙龈卟啉单胞菌的最小抑菌浓度(MIC)和最小杀菌浓度(MBC);MTT法检测KSL和KSL-W对成骨样细胞MG-63的细胞毒性。结果 KSL和KSL-W对具梭核杆菌的MIC和MBC分别为0.015 6 mg/mL和0.031 3 mg/mL,对牙龈卟啉单胞菌的MIC和MBC分别为0.125 mg/mL和0.5 mg/mL,在0.5 mg/mL的浓度范围内对血链球菌没有抑制作用;KSL和KSL-W在0.5 mg/mL的浓度范围内没有细胞毒性。结论 KSL和KSL-W没有细胞毒性,对具梭核杆菌和牙龈卟啉单胞菌具有抑制作用。 Objective To study the inhibitory effect of antimicrobial peptides KSL and its analogues on peri-implantitis pathogens in vitro. Methods The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of KSL and KSL-W against S. sanguis, F. nucleatum, and P. gingivalis were detected by doubling dilution. Cytotoxicity of KSL and KSL-W were assessed hy the MTT assay. Results The MIC and MBC of KSL and KSL-W to F. nucleatum were 0. 0156 mg/mL and 0. 0313 mg/mL, those to P. gingivalis were 0. 125 mg/mL and 0.5 mg/mL, while those to S. sanguis were not measured under the concentration of 0.5 mg/mL. KSL and KSL-W showed no cytotoxicity under the concentration of 0.5 mg/mL. Conclusion Antimicrobial peptides KSL and KSL-W have no cytotoxieity, but inhibitory effect on F. nucleatum and P. gingivalis.
出处 《中国微生态学杂志》 CAS CSCD 2014年第7期760-763,共4页 Chinese Journal of Microecology
基金 国家自然科学基金(81000669) 辽宁省自然科学基金(201102045)
关键词 抗菌肽 KSL 种植体周围炎 致病菌 Antimicrobial peptides KSL Peri-implantitis Pathogen
  • 相关文献

参考文献17

  • 1Miguel PD, Araceli BL, Berta GM. Inflammatoly implant periapical lesion: etiology, diagnosis, and treatment-presentation of 7 eases [ J]. J Oral Maxillofac Surg, 2009, 67 ( 1 ) : 168-73.
  • 2Heitz-Mayfield LJ. Peri-implant diseases: diagnosis and risk indica- tors[J]. J Clin Periodontol, 2008, 35(8) : 292-304.
  • 3Chan HL, Lin GH, Suarez F, et al. Surgical management of peri- implantitis: a systematic review and Meta-analysis of treatment out- comes[ J]. J Periodontol, 2013. [ Epub ahead of print].
  • 4Khoshkam V, Chan HL, Lin GH, et al. Reconstructive procedures for treating peri-implantitis: a systematic review [ J ]. J Dent Res, 2013, 92(12): 131S-138S.
  • 5周学东,肖晓蓉.口腔微生物[M].成都:四川大学出版社,2002:384-392.
  • 6Mosmann T. Rapid colorimetric assay for cellular growth and surviv- al: application to proliferation and cytotoxicity assays [ J ]. J Immu- nol Methods, 1983, 65(1-2) : 55-63.
  • 7宋晓波.血链球菌与口腔微生态的关系[J].中国微生态学杂志,1997,9(6):46-47. 被引量:2
  • 8Paster BJ, Boehes SK, Gal vin JL, et at. Bacterial diversity in hu- man subgingival plaque[ J]. J Baeteriol, 2001, 183 (12) : 3770- 3783.
  • 9Polak D, Shapira L, Weiss EI, et al. The role of ca,aggregation be- tween Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection[ J]. J Clin Periodontol, 2012, 39 (7) : 617-625.
  • 10Signat B, Roques C, Poulet P, et al. Role of Fusobacterium nu- cleatum in periodontal health and disease [ J ]. Curr Issues Mol Bi- ol, 2011, 13(1): 25-36.

二级参考文献1

共引文献7

同被引文献61

  • 1邢联平,张倩,姚振强.破骨细胞介导炎症性骨丢失的研究进展[J].中华创伤骨科杂志,2006,8(7):671-674. 被引量:8
  • 2周学东,肖晓蓉.口腔微生物[M].成都:四川大学出版社,2002:384-392.
  • 3Maisetta G, Mangoni ML, Esin S, ct al. In vitro bactericidal activ- ity of the N-terminal fragment of the frog peptide esculentin-lb( Esc 1-18) in combination with conventional antibiotics against Stenotro- phomonas maltophilia[J]. Peptides, 2009, 30(9) : 1622-1626.
  • 4Jcrala R, Porto M. Endotoxin neutralizing peptides [ J ]. Curr Top Med Chem, 2004, 4(11): 1173-1184.
  • 5Lai Y, Gallo RL. AMPed up immunity: how anti-microbial peptides have multiple roles in immune defense [ J ]. Trends Immunol, 2009, 30(3): 131-141.
  • 6Melo MN, Ferre R, Castanho MARB. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations [J].Nat Rev Microbiol, 2009, 7(3): 245-250.
  • 7Gomes PS, Fernandes MH. Defensins in the oral cavity : distributio- hand biological role[J]. J Oral Pathol Med, 2010, 39( 1 ) : 1-9.
  • 8Tao R, Tong Z, Lin Y, et al. Antimicrobial and antibiofilm activity of pleuroeidin against cariogenic mieroorganisms [ J ]. Peptides, 2011, 32(8) : 1748-1754.
  • 9Harro JM, Peters BM, O'May GA, et al. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into considera- tion[J]. FEMS Immunol Med Mic, 2010, 59(3) : 306-323.
  • 10Lin P, Li Y, Dong K, et al. The Antibacterial Effects of an Anti- microbial Peptide Human β-Defensin 3 Fused with Carbohydrate- Binding Domain on Pseudomonas aeruginosa PAl4 [ J ]. CurrMicro- biol, 2015, Apr 11. [Epub ahead of print].

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部